Monroe Bank & Trust MI Buys 27 Shares of Danaher Corporation (DHR)
Monroe Bank & Trust MI increased its stake in shares of Danaher Corporation (NYSE:DHR) by 0.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,750 shares of the conglomerate’s stock after acquiring an additional 27 shares during the quarter. Monroe Bank & Trust MI’s holdings in Danaher Corporation were worth $1,161,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently bought and sold shares of DHR. Waldron LP purchased a new stake in shares of Danaher Corporation during the first quarter valued at approximately $320,000. Empire Life Investments Inc. grew its holdings in shares of Danaher Corporation by 2.3% in the first quarter. Empire Life Investments Inc. now owns 77,900 shares of the conglomerate’s stock worth $6,662,000 after purchasing an additional 1,764 shares during the last quarter. Elkhorn Investments LLC bought a new position in shares of Danaher Corporation in the first quarter worth approximately $1,301,000. Advisors Asset Management Inc. grew its holdings in shares of Danaher Corporation by 6.9% in the first quarter. Advisors Asset Management Inc. now owns 81,481 shares of the conglomerate’s stock worth $6,969,000 after purchasing an additional 5,271 shares during the last quarter. Finally, American Century Companies Inc. grew its holdings in shares of Danaher Corporation by 108.5% in the first quarter. American Century Companies Inc. now owns 1,928,414 shares of the conglomerate’s stock worth $164,937,000 after purchasing an additional 1,003,306 shares during the last quarter. Institutional investors and hedge funds own 75.68% of the company’s stock.
Several research analysts recently commented on the stock. Janney Montgomery Scott downgraded shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. BidaskClub cut shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Thursday, June 15th. Zacks Investment Research lowered shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Monday, June 19th. Deutsche Bank AG reissued a “buy” rating and issued a $97.00 price target on shares of Danaher Corporation in a report on Wednesday, June 21st. Finally, Royal Bank Of Canada restated a “hold” rating and issued a $88.00 price objective on shares of Danaher Corporation in a research report on Wednesday, July 12th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. Danaher Corporation currently has a consensus rating of “Buy” and a consensus price target of $91.98.
In related news, insider William King sold 7,458 shares of the stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the transaction, the insider now owns 18,245 shares of the company’s stock, valued at $1,513,787.65. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the firm’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the transaction, the insider now owns 155,520 shares in the company, valued at $12,718,425.60. The disclosure for this sale can be found here. Insiders have sold 71,496 shares of company stock valued at $5,916,223 in the last ninety days. Insiders own 12.20% of the company’s stock.
Shares of Danaher Corporation (NYSE DHR) opened at 86.52 on Tuesday. The company has a market capitalization of $60.10 billion, a price-to-earnings ratio of 27.62 and a beta of 1.03. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.62. The company’s 50 day moving average price is $84.37 and its 200 day moving average price is $84.14.
Danaher Corporation (NYSE:DHR) last issued its earnings results on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, topping the Zacks’ consensus estimate of $0.97 by $0.02. The business had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.90 EPS. On average, analysts predict that Danaher Corporation will post $3.95 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be paid a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a dividend yield of 0.65%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s dividend payout ratio is presently 17.83%.
WARNING: “Monroe Bank & Trust MI Buys 27 Shares of Danaher Corporation (DHR)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/10/03/monroe-bank-trust-mi-buys-27-shares-of-danaher-corporation-dhr.html.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.